EP3464278 - XANTHONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 22.04.2022 Database last updated on 24.08.2024 | |
Former | The patent has been granted Status updated on 14.05.2021 | ||
Former | Grant of patent is intended Status updated on 20.01.2021 | ||
Former | Examination is in progress Status updated on 05.10.2019 | ||
Former | Request for examination was made Status updated on 08.03.2019 | ||
Former | The international publication has been made Status updated on 01.12.2017 | ||
Former | unknown Status updated on 15.06.2017 | Most recent event Tooltip | 14.06.2024 | Lapse of the patent in a contracting state New state(s): TR | published on 17.07.2024 [2024/29] | Applicant(s) | For all designated states F. Hoffmann-La Roche AG Grenzacherstrasse 124 4070 Basel / CH | [2019/15] | Inventor(s) | 01 /
CHEN, Dongdong Building No. 5 Lane 720 Cailun Road Shanghai 201203 / CN | 02 /
CHEN, Wenming Building No. 5 Lane 720 Cailun Road Shanghai 201203 / CN | 03 /
FENG, Song Building No. 5 Lane 720 Cailun Road Shanghai 201203 / CN | 04 /
GAO, Lu Building No. 5 Lane 720 Cailun Road Shanghai 201203 / CN | 05 /
SHEN, Hong Building No. 5 Lane 720 Cailun Road Shanghai 201203 / CN | 06 /
TAN, Xuefei Building No. 5 Lane 720 Cailun Road Shanghai 201203 / CN | 07 /
WANG, Li Building No. 5 Lane 720 Cailun Road Shanghai 201203 / CN | [2019/15] | Representative(s) | Bernard, Guillaume F. Hoffmann-La Roche AG Patent Department Grenzacherstrasse 124 4070 Basel / CH | [2019/15] | Application number, filing date | 17726894.3 | 23.05.2017 | [2019/15] | WO2017EP62320 | Priority number, date | WO2016CN83472 | 26.05.2016 Original published format: PCT/CN2016/083472 | WO2017CN80914 | 18.04.2017 Original published format: PCT/CN2017/080914 | [2019/15] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017202798 | Date: | 30.11.2017 | Language: | EN | [2017/48] | Type: | A1 Application with search report | No.: | EP3464278 | Date: | 10.04.2019 | Language: | EN | The application published by WIPO in one of the EPO official languages on 30.11.2017 takes the place of the publication of the European patent application. | [2019/15] | Type: | B1 Patent specification | No.: | EP3464278 | Date: | 16.06.2021 | Language: | EN | [2021/24] | Search report(s) | International search report - published on: | EP | 30.11.2017 | Classification | IPC: | C07D405/14, C07D311/82, C07D311/86, C07D405/04, C07D407/04, C07D409/04, C07D487/10, C07D491/052, C07D493/10, A61K31/352, A61P31/12 | [2019/15] | CPC: |
C07D311/86 (EP,US);
A61P31/20 (EP,US);
C07D311/82 (EP,US);
C07D405/04 (EP,US);
C07D405/14 (EP,US);
C07D407/04 (EP,US);
C07D409/04 (EP,US);
C07D487/10 (EP,US);
C07D491/052 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/15] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | Not yet paid | MD | Not yet paid | Title | German: | XANTHONDERIVATE ZUR BEHANDLUNG UND PROPHYLAXE VON HEPATITIS-B-VIRUSERKRANKUNGEN | [2021/07] | English: | XANTHONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE | [2019/15] | French: | DÉRIVÉS DE XANTHONE POUR LE TRAITEMENT ET LA PROPHYLAXIE D'UNE MALADIE À VIRUS DE L'HÉPATITE B | [2019/15] |
Former [2019/15] | XANTHONDERIVATE ZUR BEHANDLUNG UND PROPHYLAXE VON HEPATITIS-B-VIRUSERKRANUNGEN | Entry into regional phase | 02.01.2019 | National basic fee paid | 02.01.2019 | Designation fee(s) paid | 02.01.2019 | Examination fee paid | Examination procedure | 02.01.2019 | Examination requested [2019/15] | 02.01.2019 | Date on which the examining division has become responsible | 17.07.2019 | Amendment by applicant (claims and/or description) | 09.10.2019 | Despatch of a communication from the examining division (Time limit: M06) | 02.04.2020 | Reply to a communication from the examining division | 06.08.2020 | Despatch of a communication from the examining division (Time limit: M04) | 24.11.2020 | Reply to a communication from the examining division | 21.01.2021 | Communication of intention to grant the patent | 23.04.2021 | Fee for grant paid | 23.04.2021 | Fee for publishing/printing paid | 23.04.2021 | Receipt of the translation of the claim(s) | Opposition(s) | 17.03.2022 | No opposition filed within time limit [2022/21] | Fees paid | Renewal fee | 08.05.2019 | Renewal fee patent year 03 | 30.03.2020 | Renewal fee patent year 04 | 11.05.2021 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 23.05.2017 | AL | 16.06.2021 | AT | 16.06.2021 | CY | 16.06.2021 | CZ | 16.06.2021 | DK | 16.06.2021 | EE | 16.06.2021 | ES | 16.06.2021 | FI | 16.06.2021 | HR | 16.06.2021 | IT | 16.06.2021 | LT | 16.06.2021 | LV | 16.06.2021 | MC | 16.06.2021 | MK | 16.06.2021 | NL | 16.06.2021 | PL | 16.06.2021 | RO | 16.06.2021 | RS | 16.06.2021 | SE | 16.06.2021 | SI | 16.06.2021 | SK | 16.06.2021 | SM | 16.06.2021 | TR | 16.06.2021 | BG | 16.09.2021 | NO | 16.09.2021 | GR | 17.09.2021 | IS | 16.10.2021 | PT | 18.10.2021 | [2024/29] |
Former [2024/22] | HU | 23.05.2017 | |
AL | 16.06.2021 | ||
AT | 16.06.2021 | ||
CY | 16.06.2021 | ||
CZ | 16.06.2021 | ||
DK | 16.06.2021 | ||
EE | 16.06.2021 | ||
ES | 16.06.2021 | ||
FI | 16.06.2021 | ||
HR | 16.06.2021 | ||
IT | 16.06.2021 | ||
LT | 16.06.2021 | ||
LV | 16.06.2021 | ||
MC | 16.06.2021 | ||
MK | 16.06.2021 | ||
NL | 16.06.2021 | ||
PL | 16.06.2021 | ||
RO | 16.06.2021 | ||
RS | 16.06.2021 | ||
SE | 16.06.2021 | ||
SI | 16.06.2021 | ||
SK | 16.06.2021 | ||
SM | 16.06.2021 | ||
BG | 16.09.2021 | ||
NO | 16.09.2021 | ||
GR | 17.09.2021 | ||
IS | 16.10.2021 | ||
PT | 18.10.2021 | ||
Former [2024/20] | HU | 23.05.2017 | |
AL | 16.06.2021 | ||
AT | 16.06.2021 | ||
CY | 16.06.2021 | ||
CZ | 16.06.2021 | ||
DK | 16.06.2021 | ||
EE | 16.06.2021 | ||
ES | 16.06.2021 | ||
FI | 16.06.2021 | ||
HR | 16.06.2021 | ||
IT | 16.06.2021 | ||
LT | 16.06.2021 | ||
LV | 16.06.2021 | ||
MC | 16.06.2021 | ||
NL | 16.06.2021 | ||
PL | 16.06.2021 | ||
RO | 16.06.2021 | ||
RS | 16.06.2021 | ||
SE | 16.06.2021 | ||
SI | 16.06.2021 | ||
SK | 16.06.2021 | ||
SM | 16.06.2021 | ||
BG | 16.09.2021 | ||
NO | 16.09.2021 | ||
GR | 17.09.2021 | ||
IS | 16.10.2021 | ||
PT | 18.10.2021 | ||
Former [2024/18] | HU | 23.05.2017 | |
AL | 16.06.2021 | ||
AT | 16.06.2021 | ||
CZ | 16.06.2021 | ||
DK | 16.06.2021 | ||
EE | 16.06.2021 | ||
ES | 16.06.2021 | ||
FI | 16.06.2021 | ||
HR | 16.06.2021 | ||
IT | 16.06.2021 | ||
LT | 16.06.2021 | ||
LV | 16.06.2021 | ||
MC | 16.06.2021 | ||
NL | 16.06.2021 | ||
PL | 16.06.2021 | ||
RO | 16.06.2021 | ||
RS | 16.06.2021 | ||
SE | 16.06.2021 | ||
SI | 16.06.2021 | ||
SK | 16.06.2021 | ||
SM | 16.06.2021 | ||
BG | 16.09.2021 | ||
NO | 16.09.2021 | ||
GR | 17.09.2021 | ||
IS | 16.10.2021 | ||
PT | 18.10.2021 | ||
Former [2023/06] | AL | 16.06.2021 | |
AT | 16.06.2021 | ||
CZ | 16.06.2021 | ||
DK | 16.06.2021 | ||
EE | 16.06.2021 | ||
ES | 16.06.2021 | ||
FI | 16.06.2021 | ||
HR | 16.06.2021 | ||
IT | 16.06.2021 | ||
LT | 16.06.2021 | ||
LV | 16.06.2021 | ||
MC | 16.06.2021 | ||
NL | 16.06.2021 | ||
PL | 16.06.2021 | ||
RO | 16.06.2021 | ||
RS | 16.06.2021 | ||
SE | 16.06.2021 | ||
SI | 16.06.2021 | ||
SK | 16.06.2021 | ||
SM | 16.06.2021 | ||
BG | 16.09.2021 | ||
NO | 16.09.2021 | ||
GR | 17.09.2021 | ||
IS | 16.10.2021 | ||
PT | 18.10.2021 | ||
Former [2022/36] | AL | 16.06.2021 | |
AT | 16.06.2021 | ||
CZ | 16.06.2021 | ||
DK | 16.06.2021 | ||
EE | 16.06.2021 | ||
ES | 16.06.2021 | ||
FI | 16.06.2021 | ||
HR | 16.06.2021 | ||
IT | 16.06.2021 | ||
LT | 16.06.2021 | ||
LV | 16.06.2021 | ||
NL | 16.06.2021 | ||
PL | 16.06.2021 | ||
RO | 16.06.2021 | ||
RS | 16.06.2021 | ||
SE | 16.06.2021 | ||
SI | 16.06.2021 | ||
SK | 16.06.2021 | ||
SM | 16.06.2021 | ||
BG | 16.09.2021 | ||
NO | 16.09.2021 | ||
GR | 17.09.2021 | ||
IS | 16.10.2021 | ||
PT | 18.10.2021 | ||
Former [2022/29] | AL | 16.06.2021 | |
AT | 16.06.2021 | ||
CZ | 16.06.2021 | ||
DK | 16.06.2021 | ||
EE | 16.06.2021 | ||
ES | 16.06.2021 | ||
FI | 16.06.2021 | ||
HR | 16.06.2021 | ||
LT | 16.06.2021 | ||
LV | 16.06.2021 | ||
NL | 16.06.2021 | ||
PL | 16.06.2021 | ||
RO | 16.06.2021 | ||
RS | 16.06.2021 | ||
SE | 16.06.2021 | ||
SI | 16.06.2021 | ||
SK | 16.06.2021 | ||
SM | 16.06.2021 | ||
BG | 16.09.2021 | ||
NO | 16.09.2021 | ||
GR | 17.09.2021 | ||
IS | 16.10.2021 | ||
PT | 18.10.2021 | ||
Former [2022/26] | AL | 16.06.2021 | |
AT | 16.06.2021 | ||
CZ | 16.06.2021 | ||
DK | 16.06.2021 | ||
EE | 16.06.2021 | ||
ES | 16.06.2021 | ||
FI | 16.06.2021 | ||
HR | 16.06.2021 | ||
LT | 16.06.2021 | ||
LV | 16.06.2021 | ||
NL | 16.06.2021 | ||
PL | 16.06.2021 | ||
RO | 16.06.2021 | ||
RS | 16.06.2021 | ||
SE | 16.06.2021 | ||
SK | 16.06.2021 | ||
SM | 16.06.2021 | ||
BG | 16.09.2021 | ||
NO | 16.09.2021 | ||
GR | 17.09.2021 | ||
IS | 16.10.2021 | ||
PT | 18.10.2021 | ||
Former [2022/21] | AT | 16.06.2021 | |
CZ | 16.06.2021 | ||
DK | 16.06.2021 | ||
EE | 16.06.2021 | ||
ES | 16.06.2021 | ||
FI | 16.06.2021 | ||
HR | 16.06.2021 | ||
LT | 16.06.2021 | ||
LV | 16.06.2021 | ||
NL | 16.06.2021 | ||
PL | 16.06.2021 | ||
RO | 16.06.2021 | ||
RS | 16.06.2021 | ||
SE | 16.06.2021 | ||
SK | 16.06.2021 | ||
SM | 16.06.2021 | ||
BG | 16.09.2021 | ||
NO | 16.09.2021 | ||
GR | 17.09.2021 | ||
IS | 16.10.2021 | ||
PT | 18.10.2021 | ||
Former [2022/10] | AT | 16.06.2021 | |
CZ | 16.06.2021 | ||
EE | 16.06.2021 | ||
ES | 16.06.2021 | ||
FI | 16.06.2021 | ||
HR | 16.06.2021 | ||
LT | 16.06.2021 | ||
LV | 16.06.2021 | ||
NL | 16.06.2021 | ||
PL | 16.06.2021 | ||
RO | 16.06.2021 | ||
RS | 16.06.2021 | ||
SE | 16.06.2021 | ||
SK | 16.06.2021 | ||
SM | 16.06.2021 | ||
BG | 16.09.2021 | ||
NO | 16.09.2021 | ||
GR | 17.09.2021 | ||
IS | 16.10.2021 | ||
PT | 18.10.2021 | ||
Former [2022/09] | AT | 16.06.2021 | |
CZ | 16.06.2021 | ||
ES | 16.06.2021 | ||
FI | 16.06.2021 | ||
HR | 16.06.2021 | ||
LT | 16.06.2021 | ||
LV | 16.06.2021 | ||
NL | 16.06.2021 | ||
RO | 16.06.2021 | ||
RS | 16.06.2021 | ||
SE | 16.06.2021 | ||
SK | 16.06.2021 | ||
SM | 16.06.2021 | ||
BG | 16.09.2021 | ||
NO | 16.09.2021 | ||
GR | 17.09.2021 | ||
PT | 18.10.2021 | ||
Former [2022/08] | AT | 16.06.2021 | |
CZ | 16.06.2021 | ||
ES | 16.06.2021 | ||
FI | 16.06.2021 | ||
HR | 16.06.2021 | ||
LT | 16.06.2021 | ||
LV | 16.06.2021 | ||
NL | 16.06.2021 | ||
RS | 16.06.2021 | ||
SE | 16.06.2021 | ||
SM | 16.06.2021 | ||
BG | 16.09.2021 | ||
NO | 16.09.2021 | ||
GR | 17.09.2021 | ||
Former [2022/07] | AT | 16.06.2021 | |
FI | 16.06.2021 | ||
HR | 16.06.2021 | ||
LT | 16.06.2021 | ||
LV | 16.06.2021 | ||
NL | 16.06.2021 | ||
RS | 16.06.2021 | ||
SE | 16.06.2021 | ||
SM | 16.06.2021 | ||
BG | 16.09.2021 | ||
NO | 16.09.2021 | ||
GR | 17.09.2021 | ||
Former [2021/51] | FI | 16.06.2021 | |
HR | 16.06.2021 | ||
LT | 16.06.2021 | ||
LV | 16.06.2021 | ||
RS | 16.06.2021 | ||
SE | 16.06.2021 | ||
BG | 16.09.2021 | ||
NO | 16.09.2021 | ||
GR | 17.09.2021 | ||
Former [2021/49] | FI | 16.06.2021 | |
HR | 16.06.2021 | ||
LT | 16.06.2021 | ||
LV | 16.06.2021 | ||
SE | 16.06.2021 | ||
BG | 16.09.2021 | ||
NO | 16.09.2021 | ||
GR | 17.09.2021 | ||
Former [2021/47] | FI | 16.06.2021 | |
LT | 16.06.2021 | ||
BG | 16.09.2021 | ||
Former [2021/46] | FI | 16.06.2021 | |
LT | 16.06.2021 | Cited in | International search | [A]US2012184578 (TEOW VINCENT I [US]) [A] 1-37 * example - * * claim - * * claim 1 * * page 8 *; | [AD]CN104370871 (UNIV BEIJING) [AD] 1-37 * example - * * claim - *; | [A] - ZHANG FAN ET AL, "A review of non-nucleoside anti-hepatitis B virus agents", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, (20141230), vol. 75, doi:10.1016/J.EJMECH.2014.01.046, ISSN 0223-5234, pages 267 - 281, XP028625376 [A] 1-37 * abstract * * page 268; figure 1 * DOI: http://dx.doi.org/10.1016/j.ejmech.2014.01.046 | Examination | - Pubchem, "1-[5-Fluoro-9-(oxetan-3-yl)-9H-xanthen-3-yl]pyrrolidine | C20H20FNO2 - PubChem", (20160301), URL: https://pubchem.ncbi.nlm.nih.gov/compound/138687203, (20200731), XP055719525 | by applicant | CN104370871 | - LOZANO, R ET AL., LANCET, (2012), vol. 380, no. 9859, pages 2095 - 2128 | - GOLDSTEIN, S.T. ET AL., INT J EPIDEMIOL, (2005), vol. 34, no. 6, pages 1329 - 1339 | - CHEN, D.S., J HEPATOL, (2009), vol. 50, no. 4, pages 805 - 816 | - LI, X.M ET AL., WORLD J GASTROENTEROL, (2003), vol. 9, no. 7, pages 1501 - 1503 | - AHMED, M ET AL., DRUG DISCOV TODAY, (2015), vol. 20, no. 5, pages 548 - 561 | - ZOULIM, F.; LOCARNINI, S., GASTROENTEROLOGY, (2009), vol. 137, no. 5, pages 1593 - 1608 E1591,1592 | - NASSAL, M., GUT, (2015), vol. 64, no. 12, pages 1972 - 1984 | - GISH, R.G ET AL., ANTIVIRAL RES, (2015), vol. 121, pages 47 - 58 | - LEVRERO, M ET AL., J HEPATOL, (2009), vol. 51, no. 3, pages 581 - 592 | - AHMED, M. ET AL., DRUG DISCOV TODAY, (2015), vol. 20, no. 5, pages 548 - 561 | - BASTIN R.J. ET AL., ORGANIC PROCESS RESEARCH & DEVELOPMENT, (2000), vol. 4, pages 427 - 435 | - PEGG, DAVID E., "Principles of cryopreservation", METHODS IN MOLECULAR BIOLOGY, (20070101), vol. 368, pages 39 - 57 | - ZHOU, T ET AL., ANTIVIRAL RES, (2006), vol. 72, no. 2, pages 116 - 124 | - GUO, H. ET AL., J. VIROL, (2007), vol. 81, no. 22, pages 12472 - 12484 |